Strasbourg, France – Ksilink, together with our collaborators from I-Stem (Paris), has recently published a scientific paper that provides significant insights into...
Ksilink Advances PMDS Research and Disease Modelling
read more
Patient-based drug discovery's latest news
New publication in “Nature Communications”
Lamiable, A., Champetier, T., Leonardi, F. et al. Revealing invisible cell phenotypes with conditional generative modeling. Nat Commun 14, 6386 (2023). Biological sciences, drug...
New publication in the journal ‘Stem Cell Research’
Chatrousse et al., Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9....
New publication in Journal of Visualized Experiments
Weiss A, Sommer P, Wilbertz JH. Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons. J Vis Exp. 2023 Jul 7;(197). doi: 10.3791/65570. PMID: 37486112...
A new publication of the environMENTAL consortium in Nature Medicine
A new publication of the environMENTAL consortium on effects of urban living environments on mental health in adults has been just in the prestigious journal Nature Medicine The...
New publication: Machine learning-aided analysis of human dopaminergic neurons
Link to publication: https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(22)00423-4 In our most recent work in collaboration with colleagues from Life & Brain and the...
New publication: A step forward towards precision oncology
Ksilink is dedicated to foster patient-based therapeutic approaches including personalized strategies as a means to stratify potential targeted therapies in a clinically relevant...
New publication in nature genetics
Dr YongJun Kwon, Ksilink’s Head of Early Discovery and Technology Development, publishes a paper entitled “Pharmacogenomic landscape of patient-derived tumor cells informs...